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Abstract
Background: The Doctor of Nursing Practice (DNP) project focused on the delay in intravenous
fluid (IVF) resuscitation of sepsis and septic shock patients in the emergency room (ER) before
inpatient admission.
Purpose: The purpose of this project was to improve the time-sensitive administration of IVF
resuscitation of adult patients diagnosed with sepsis or septic shock by enhancing ER nurses’
end-user knowledge of and adherence to evidence-based sepsis treatment recommendations over
approximately six weeks (42 days).
Methods: Retrospective chart reviews were performed in December 2021 and focused on IVF
resuscitation times. Pre-intervention questionnaires were completed, assessing baseline nursing
knowledge. Nurse education focused on rapid IVF initiation and the importance of minimizing
delays in IVF resuscitation treatment. Participating nurses were educated on the Surviving Sepsis
Campaign’s hour-1 bundle protocol. Post-intervention questionnaires were completed, followed
by retrospective post-intervention chart reviews in February through March 2022 to evaluate
interventional impact.
Results: Pre-intervention retrospective chart reviews revealed 37.3% fallout of sepsis cases
regarding IVF resuscitation times compared to 36.8% fallout of sepsis cases post-intervention, a
difference of 0.5%. Fisher’s exact test was utilized to test for statistical significance, revealing no
statistical significance (p-value = 1.0000).
Conclusion: This project emphasizes the importance of nurse adherence to the sepsis hour-1
bundle protocol of decreasing IVF resuscitation times in hypoperfused sepsis and septic shock
patients.
Keywords: sepsis, septic shock, fluid resuscitation, emergency room

4
Acknowledgments
Completing this Doctor of Nursing Practice (DNP) project and graduate program is
dedicated to my husband, Patrick. You light up my life and are one of the most selfless people I
know. Thank you from the bottom of my heart for all you do and for being my most significant
source of strength. I love you. I would also like to acknowledge my family, including my sister
Rachael, mother, Jocelyn, and father, Stan. It is hard to describe the love shown and the
meaningful impact these three people have made on my life. I am forever grateful for them, as
their love for one another has been a beautiful example on which to build my life. I offer my
deepest gratitude for all of your encouragement throughout my nursing journey, and I promise to
emulate each of your beautiful souls throughout my professional career.
I want to express tremendous gratitude to three phenomenal nurses and colleagues I am
privileged to work alongside, my preceptor Dr. Stephanie Jones, and mentor, Dr. Brian Keith
Brooks, for being great cheerleaders during my continued growth and development as a nurse,
and the hospital Sepsis Coordinator, Emily Rakestraw, for assisting me in data collection during
this project. I also want to express my sincere appreciation and heartfelt thanks to my DNP
faculty chair, Dr. Timothy Blake Booth, professor Dr. Lori McGrath, and the Jacksonville State
University nursing faculty and staff. The fundamental foundation provided throughout this DNP
program was challenging, yet I am forever grateful for being part of such an esteemed
experience. As I progress in my professional career, I will carry all I have learned and
accomplished, applying it in clinical practice to provide high-quality, evidence-based patient
care. Thank you for giving me the tools necessary to be a difference-maker, as your personal and
educational impact will be forever invaluable.

5
Table of Contents
Abstract ……...…………………………………………………………………………………... 3
Introduction ……...……….……………………………………………………………………… 8
Background ……...……….……………………………………………………………………… 9
Needs Analysis ….………………………………………………………………………………. 9
The Emergency Room ...……………………………………………………...…….….. 10
SWOT Analysis…...……………………………………………………………………... 10
Problem Statement (PICOT) ……...………...………………………………………………….. 12
Aims and Objectives ……...….………………………………………………………………… 12
Review of Literature ……...….………………………………………………………………… 13
Early Sepsis…………….……………………………………………………….. 14
Sepsis (Severe Sepsis).……………..……………………………………..…….. 15
Septic Shock…….…………………………………………………………......... 16
Multiple Organ Dysfunction Syndrome (MODS)…………………………........ 16
COVID-19 Special Considerations……………………………………………... 16
Management of Sepsis and Septic Shock………………………………………. 17
Theoretical Framework ……...……………………………………………………………......... 20
Methodology ……...……………………………………………………………………………. 20
Setting…………………………………………………………………………... 21
Population………………………………………………………………………. 21
Inclusion and Exclusion Nursing Criteria………………………………………. 21
Recruitment and Consent.………………………………………….………….... 22
Design…………………………………………………………………………... 22

6
Chart Reviews………………………………………………………………....... 23
Risks and Benefits…………………………………………………………......... 24
Timeline………………………………………………………………………… 25
Budget and Resources…………………………………………………………... 25
Evaluation Plan ……...…………………………………………………………………………. 25
Statistical Considerations……………………………………………………….. 25
Data Maintenance and Security………………………………………………… 26
Results ……....………………………………………………………………………………….. 26
Results of Chart Reviews……………………………………………………….. 26
Results of Questionnaire Responses……………………………………………. 28
Discussion ……...………………………………………………………………………………. 31
Implications………………………………………………………………........... 32
Limitations………………………………………………………………........… 33
Dissemination ……...…………………………………………………………………………... 34
Plans for Future Scholarship ……..……………………………………………………………. 35
Sustainability……………………………………………………………………. 35
Conclusion ……....……………………………………………………………………………... 36
References ……...…………………………………………………………………………......... 37
Appendices ……...……………………………………………………………………………… 41
Appendix A: Participant Consent Form ………………………………………... 41
Appendix B: Pre-Intervention Retrospective Chart Reviews ……….................. 42
Appendix C: Doctor of Nursing Practice (DNP) Project Timeline…………….. 48
Appendix D: Budget……………………………………………………………. 49

7
Appendix E: Post-Intervention Retrospective Chart Reviews …………...…….. 50
Appendix F: Quality Improvement Evaluation Pre-Intervention Questionnaire.. 52
Appendix G: Quality Improvement Evaluation Post-Intervention Questionnaire 53
Appendix H: Educational Session Resource…………………………...……….. 54
Appendix I: Citi Program Certificate………………………………………….... 55
Appendix J: Jacksonville State University IRB Letter of Approval………..…... 56

8
Improving Intravenous Fluid Resuscitation Compliance of Severe Septic and Septic Shock
Adults in a Rural Emergency Room
Sepsis is dangerously characterized by an interruption in host deviation from normal
physiological, biological, and metabolic states due to infection. The body produces an
inflammatory response during sepsis, resulting in multiple organ dysfunction syndromes
(MODS) and potential death if left untreated (Neviere, 2021). The term sepsis is generalized and
presents on the following severity scale: (a) varying infection to bacteremia, (b) bacteremia to
sepsis, (c) sepsis to septic shock, and (d) septic shock to MODS and death. Since the 1990s,
sepsis and septic shock terminology has evolved (Neviere, 2021).
The Center for Medicare and Medicaid Services (CMS) utilizes definitions of Systemic
Inflammatory Response Syndrome (SIRS), sepsis, and severe sepsis. The Society of Critical
Care Medicine (SSCM) and the European Society of Intensive Care Medicine (ESICM)
generally do not accept the definitions used by CMS regarding sepsis. The Infectious Disease
Society of America (IDSA) does not support the 2016 guidelines set by the SCCM and the
ESICM, as the IDSA disagrees with the notion that a universal or standardized approach left out
a clear delineation between sepsis and septic shock to appropriately treat and save the lives of
patients in a state of shock. However, as discussed by the IDSA, using the definitions listed
above poses risks in over-treatment with broad-spectrum antibiotics and aggressive intravenous
fluid (IVF) resuscitation therapy for those in lesser severe conditions of sepsis (Schmidt &
Mandel, 2021). The Doctor of Nursing Practice (DNP) project focused on intravenous fluid
(IVF) resuscitation delays in patients diagnosed with severe sepsis and septic shock before
transferring from the Emergency Room to inpatient status. The overarching, purposeful goal was
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to improve IVF resuscitation through increased nurse awareness and productive adherence to
sepsis treatment implementation.
Background
Sepsis continues to be a rampant diagnosis in hospitals across the United States (U.S.),
affecting upwards of 750,000 patients yearly and killing nearly 210,000 annually (Dugar et al.,
2020). A septic patient’s average hospital length of stay (LOS) is 75% greater than other medical
diagnoses in the U.S. In 2013, the average LOS for patients with sepsis substantially increased,
with the following averages specific to each severity category of sepsis: (a) sepsis 4.5 days, (b)
severe sepsis 6.5 days, and (c) septic shock 16.5 days (Paoli et al., 2018). Georgia ranked 8th in
the U.S. for sepsis-related deaths in 2017, with a mortality rate of 15.2% (1,611 deaths per
100,000 total population) (Centers for Disease Control and Prevention [CDC], 2021). The
national percentage of septic and septic shock patients who receive appropriate care is 57%, with
Georgia at 56% (Center for Medicare and Medicaid Services [CMS], 2021).
Needs Analysis
The DNP project was conducted at a rural Northwest Georgia hospital. The facility
houses approximately 230-beds and is a level III trauma center with national recognition in
stroke (certified advanced primary stroke center) and cardiovascular care (heart failure and
myocardial infarction) through the Joint Commission. The hospital also provides advanced
cardiac surgical services, including open-heart surgery, with additional services including cancer,
diabetes, digestive, and imaging care. Other services include orthopedic care, specifically
robotic-assisted joint replacement, general surgical services, occupational health services, sports
medicine, rehabilitation, and wound care. The hospital recently added a residency program,
becoming a teaching facility in 2017.
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The rural Northwest Georgia hospital reports an average of 75% sepsis and septic shock
appropriate care (CMS, 2021). Current hospital protocol guidelines fall under the Centers for
Medicare and Medicaid Services (CMS) SEP-1 bundle protocol, where “SEP-1” stands for “The
Severe Sepsis and Septic Shock Management Bundle.” The bundle includes antibiotic and IVF
administration, blood cultures, lactic acid measurement, use of vasopressors for hypotension, and
evaluation of the patient’s response to therapy. Hospitals must report compliance with bundle
factors within three and six hours (Barbash, Davis, & Kahn, 2019). Due to the Coronavirus
(COVID-19) pandemic, hospitals are experiencing higher volumes of patients. As a result,
patients often experience a lengthy delay between the Emergency Room (ER) and admission to
an inpatient unit. Evidenced-based research education is needed to enhance ER nurses’
understanding of hospital protocol and sepsis bundle implementation as a pathway to decreasing
patients’ hospital LOS.
The Emergency Room
The ER houses 24 beds, two of which are trauma rooms. The nursing staff consists of 38
nurses, including 19 staff nurses and 19 travel agency nurses. Hospital-employed nurses on
dayshift include seven full-time, one part-time, and three per diem nurses with ten more
contracted agency travel nurses. Mid-shift has zero employees for full-time, part-time, and per
diem positions. Nightshift nurse staffing consists of eight full-time employees, zero part-time,
zero per diem hospital employees, and nine contracted through travel agencies.
SWOT Analysis
The principal investigator (PI) performed an analysis of strengths, weaknesses,
opportunities, and threats (SWOT) to assess internal and external characteristic threats related to
the project’s interest (Moran et al., 2020). Inner strengths included monitoring sepsis treatment
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initiation by the quality department, including monitoring sepsis tracers, and the hospital’s
employment of a nurse serving as the sepsis coordinator to oversee all aspects of sepsis
monitoring. CMS (2021) reports an average of 77% appropriate care regarding sepsis and septic
shock within the hospital. The principal investigator piqued interest in this DNP project because
sepsis is a monitored quality process; therefore, data exists regarding the treatment of sepsis.
A major internal and external weakness was selling the hospital to a new company. This
event affected the ability to conduct the DNP practice project; it also affected the staff
(internally) and the patients and community (externally) through positive or negative change.
Internally, the challenge of changing to a new company is a difficult transition period.
Externally, merging hospitals will likely benefit the organizational goals; however, the local
city’s potential revenue loss through taxes exists. The hospital change has gone from profit to
non-profit with the removal of county property tax, which could impact city and county schools
through budget cuts. The COVID-19 pandemic may have also contributed to the repositioning of
hospitals.
Internal weaknesses included the lack of staff buy-in. The ER consists of a mixture of
novice and seasoned staff, making a difference in the respective knowledge base regarding sepsis
treatment. As with other hospitals during the COVID-19 pandemic, nurses are burnout due to
increasing demands for higher nurse-patient ratios. The hospital utilizes more travel nurses who
may be unaware of the hospital’s treatment standards regarding sepsis and septic shock. Gaps in
care exist as delays in treatment times occur due to high census demands. Before the merge, the
Sepsis Prediction and Optimization of Therapy (SPOT) Alert System was utilized to notify
necessary parties to initiate sepsis treatment protocols immediately. However, this system will no
longer be accessible after transitioning to the operating standards of the new healthcare company.
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Since CMS reports an average of 75% appropriate care regarding sepsis and septic shock
within the hospital, timely and effective care delineates how rapidly hospitals provide care.
Evidence-based research reveals the best outcomes for patients with sepsis (CMS, 2021).
Furthermore, there are still opportunities for improvement in this number. The education of ER
nurses will aid in quality improvement regarding sepsis treatment initiation. The principal
investigator (PI) administered pre- and post-questionnaires to assess ER nurses’ general
knowledge regarding the initiation of sepsis treatment (pre), with follow-up questionnaires
evaluating knowledge gained through educational intervention (post). Due to the dangerous and
rapid threat of sepsis consequences, the need for continual assessment of staff knowledge is vital
in maintaining high-quality patient care outcomes if left untreated.
Problem Statement (PICOT)
The purpose of this DNP project was to address the following question: among adult
patients with severe sepsis/septic shock admitted to the Emergency Room (P), does timely IVF
resuscitation (I), as compared to the current Centers for Medicare and Medicaid Services (CMS)
SEP-1 bundle protocol (C), affect hospital length of stay (O)?
Aims and Objectives
The overarching aims of this project were to:
1. Improve timely intravenous fluid (IVF) resuscitation administration in severe sepsis and
septic shock patients.
a. Improve IVF resuscitation administration times by 5% post-nurse education over
six weeks (42 days)
2. Enhance nurse knowledge of sepsis and septic shock treatment through evidence-based
practice guideline awareness.
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a. Improve nurse understanding and education of IVF resuscitation through post-test
scores with a minimal 10% increase in post-test scores compared to pre-test
scores.
Review of Literature
The databases used in searching for evidence-based literature include Cumulative Index
to Nursing and Allied Health Literature (CINAHL), PubMed, Google Scholar, and Cochran
Library, using various combinations of the following key terms and phrases: (a) sepsis, (b) SIRS,
(c) severe sepsis, (d) septic shock, (e) infection, (f) emergency room, (g) sepsis guideline
management, (h) iv fluid resuscitation, (i) early goal-directed therapy, (j) nurse care guidelines,
(k) protocol compliance, (l) care bundle, (m) barriers, (n) quality of health care, (o) nursing
perceptions, (p) nursing knowledge, (q) sepsis survival, (r) sepsis outcomes, and (s) Surviving
Sepsis Campaign. Results were narrowed within the past ten years using peer-reviewed academic
journals. The elimination of articles included irrelevant content that did not discuss the project’s
purpose. Other search limiters included full text, English language, and adult-specific patient
populations. Several articles in the literature incorporated randomized control trials, systematic
reviews, cross-sectional studies, and benchmark guidelines for sepsis. The methodology of this
project was developed through critical findings of the literature search and is further discussed
below.
The overall goal of sepsis care is to reduce the time to treatment initiation. Nurses must
acknowledge prompt care for septic and septic shock patients amid life-threatening situations.
The hour-1 bundle fosters the need for nurses to act swiftly in retrieving blood cultures, initiating
broad-spectrum antibiotics, initiating intravenous fluid (IVF) resuscitation, obtaining lactate
measurements, and administering vasopressors if patients are hemodynamically unstable
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(Society of Critical Care Medicine [SCCM] & European Society of Intensive Care Medicine
[ESICM], 2021). Early recognition, including a clear understanding of pathological sepsis
findings and clinical manifestation, aids in prompt diagnosis and treatment.
Although less favorable SIRS criteria continue to be used in the DNP project’s hospital,
the hospital has undergone a buy-out from a new company, potentially changing the current
sepsis assessment tool. Since SIRS criteria are utilized at the facility, it is worth mentioning that
it tends to be less favored as evidence shows it may or may not be associated with infection. The
criterion for the assessment tool measures two or more of the following (one of which must
include temperature or abnormal leukocytes): (a) a core temperature of greater than 101.3
degrees Fahrenheit or less than 96.8 degrees Fahrenheit; (b) tachycardia greater than 90 beats per
minute; (c) tachypnea greater than 20 breaths per minute; and (d) leukocytosis greater than
1,200/mm3, leukopenia less than 4,000/mm3, or greater than 10% immature band formation
(Neviere, 2021).
Early Sepsis
Early sepsis lacks a formal definition. Eventually, infection and bacteremia lead to sepsis
if left undetected and untreated. Patient monitoring is the key to prevention. Infection pertains to
the attack of organisms on healthy body tissue resulting in infectious processes. Bacteremia
relates to the presence of bacteria in the blood. Two popular scoring tools used to help identify
early sepsis are the quick Sequential (sepsis-related) Organ Failure Assessment Score (qSOFA)
and the Nation Early Warning Score (NEWS) (Neviere, 2021).
The qSOFA score assesses the mortality risk in patients outside intensive care settings. A
qSOFA score greater than or equal to two (2) indicates the potential for adverse sepsis outcomes.
The qSOFA scores the following three parameters, each worth one point: (a) a respiratory rate

15
greater than or equal to 22 per minute, (b) altered mentation, and (c) systolic blood pressure of
less than or equal to 100 millimeters of mercury (mm Hg) (Neviere, 2021). The NEWS is a
cumulative scoring system of six parameters, with the following ranges identifying the overall
risk of sepsis death: (a) zero to four, low risk; (b) five to six, medium risk; and (c) seven or
higher, high risk. The parameters assessed include respiration rate (RR), oxygen (O2) saturation,
systolic blood pressure (SBP), heart rate (HR), changes in the level of consciousness (LOC), and
temperature (Neviere, 2021).
Sepsis (Severe Sepsis)
In 2016, the Society of Critical Care Medicine (SCCM) and European Society of
Intensive Care Medicine (ESICM) task forces described sepsis as dysregulation of the host
response to an infection, causing organ dysfunction and associated high risk for mortality. CMS
continues to utilize the terminology of SIRS, sepsis, and severe sepsis. Severe sepsis worsens
due to decreased tissue perfusion resulting from increasing lactate levels and a state of oliguria.
Noninfectious disease processes are associated with a state of SIRS, with qualifying criteria,
including the following: (a) autoimmune diseases, (b) pancreatitis, (c) vasculitis, (d)
thromboembolic states, (e) burns, and (f) surgical procedures (Neviere, 2021). Tools such as the
qSOFA score of two or more points identify organ dysfunction. The qSOFA does not diagnose
sepsis or if the cause of organ dysfunction is an infective organism but aids in assessing mortality
risk. To diagnose infection, the provider must rely on infection signs and symptoms and
supporting evidence from imaging, lab data, and the patient’s response to treatment (Neviere,
2021).
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Septic Shock
Septic shock is classified as a distributive shock state and implies dangerous circulatory,
cellular, and metabolic aberrations resulting in increased patient death. As a sequela of severe
sepsis, septic shock may ensue despite treatment of adequate IVF resuscitation. Patients in septic
shock meet sepsis parameters, developing a mean arterial pressure (MAP) less than or equal to
sixty-five millimeters of mercury and have lactate levels greater than two mmol/Liter requiring
vasopressor support. Patients with septic shock have a 40% or greater chance of mortality than
patients with early sepsis or sepsis (severe sepsis) with a 10% greater mortality rate (Neviere,
2021).
Multiple Organ Dysfunction Syndrome (MODS)
Multiple Organ Dysfunction Syndrome (MODS) is a life-threatening acute state where
the body no longer maintains homeostasis without medical intervention. MODS is the terminal
state of severe body dysregulation caused by sepsis and septic shock, classified into primary and
secondary MODS terminal states. Primary MODS is a specific organ insult directly related to
injury (i.e., renal failure after developing rhabdomyolysis). Secondary MODS is an organ insult
not directly related to damage but rather the body’s reaction due to injury (i.e., respiratory
distress syndrome after developing pancreatitis). In the case of MODS, the more organs
involved, the greater the patient’s mortality risk, especially if a patient requires mechanical
ventilation (Neviere, 2021).
COVID-19 Special Considerations
COVID-19 poses new issues as it often fulfills the criteria for sepsis as the virus
possesses phenotypical traits and disease processes that align with sepsis’s diagnostic criteria.
Multiple Organ Dysfunction Syndrome (MODS) is a common issue in cases of severe COVID-
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19 that characteristically mimic sepsis (Neviere, 2021). A German health care system noted high
initial SOFA scoring for sepsis likely related to admission delays during the pandemic. The
COVID-19 pandemic took a significant toll on health care globally, leading to mortality
increases in different diseased states such as myocardial infarctions and strokes. Delays in care
also seem to place disadvantages on the time-sensitive recognition of sepsis. Higher rates of
sepsis during the pandemic are likely attributed to three causes: (a) amplified work demand of
patient to nurse ratio (a factor that influences mortality), (b) the isolation of COVID-19 positive
patients lowering chances of survival in emergencies, and (c) patients avoiding medical care
during the pandemic out of fear (Unterberg et al., 2022).
Management of Sepsis and Septic Shock
A 2021 Surviving Sepsis Campaign retrospective analysis revealed increased in-hospital
mortality of adult patients presenting to the ER with sepsis or septic shock not receiving the
initiation of 30 mL/kg of crystalloid intravenous fluid resuscitation within three hours of sepsis
onset (Evans et al., 2021). In a race against time, salvaging viable tissue occurs when IVF
resuscitation is prompt and prioritized for all patients. The recommended hour-1 bundle of IVF
resuscitation is ideal for patients who are in critical states of sepsis or septic shock, as both are
considered medical emergencies (Society of Critical Care Medicine [SCCM], 2021; European
Society of Intensive Care Medicine [ESICM], 2021).
Dugar et al. (2020) recommended that early sepsis detection, rapid implementation of
appropriate antimicrobial therapy, and adequate fluid resuscitation were equivalent to protocol
care regarding outcomes and were ultimately more cost-effective. The management of IV fluid
resuscitation occurs through rescue, optimization, stabilization, and de-escalation phases. This
study applies to the DNP project as a benchmark recommendation, providing diagnosis and

18
management guidance based on the Surviving Sepsis Campaign, CMS recommendations, the
Sepsis-3 Committee, and international consensus studies (Dugar et al., 2020).
Early IVF fluid resuscitation is essential in stabilizing tissue hypoperfusion (Levy, Evans,
& Rhodes, 2018). IVF resuscitation should occur immediately upon detection of severe
sepsis/septic shock with the goal of completion within three hours. Recommended guidelines
discuss that resuscitation efforts should involve 30 mL/kg of crystalloid IVF. However, this
recommendation is left for interpretation as a specific patient assessment plays a crucial role in
treatment, as there is a lack of literature to support an exact volume. Volume guidelines vary
because some evidence discusses an increased mortality risk for ICU patients with a positive
fluid balance (Levy, Evans, & Rhodes, 2018). Assessment of fluid status should remain ongoing
beyond initial resuscitation concerning how fluid responsive the patient remains (Levy, Evans, &
Rhodes, 2018).
Concerning the role of nursing in recognizing and timely treatment of sepsis and septic
shock, another study completed by Burney et al. (2012) performed a quantitative cross-sectional
study, which discussed evidence around early goal-directed therapy (EGDT) of sepsis treatment
implementation. The study identified and addressed barriers in sepsis protocol initiatives and
nurse baseline assessment of knowledge, attitudes, and behaviors about sepsis treatments
(Burney et al., 2012). The study’s nurses and physicians identified a critical nurse staffing
shortage as one of the most significant weaknesses in implementing protocols around early
sepsis resuscitation (Burney et al., 2012).
Screening for sepsis is essential, and initial resuscitation should begin immediately upon
recognition (Evans et al., 2021). In a retrospective analysis of ER adult patients, Evans et al.
discuss that failure to receive the recommended 30 mL/kg of IV resuscitation within three hours
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of sepsis onset was related to increased hospital mortality. Moreover, IV fluid resuscitation aims
of 30mL/kg have been adopted into routine clinical practice to reduce serum lactate and improve
perfusion. New guidelines also suggest that patients who need medical attention in an intensive
care unit (ICU) be transferred within six hours (Evans et al., 2021).
Leisman et al. (2016) reviewed a prospective observational cohort regarding severe sepsis
and septic shock patients in an ER. The study revealed that IVF resuscitation initiation time
within 30 minutes of sepsis presentation was associated with improved hospital length of stay
and patient mortality, resulting in an easier performance predictor of sepsis and septic shock time
management than IVF completion time (Leisman et al., 2016). This study may be valuable to the
DNP project as its key findings support hastening treatment times for IVF therapy. A study by
Gaieski et al. (2017) concluded that the impact of ER crowding plays a significant role in the
follow-through of protocolized sepsis care. The study revealed that as ER crowding surges
occurred, time to critical sepsis therapy significantly increased while protocolized care
decreased. As crowding occurs, emphasizing quality improvement plans to enhance timesensitive therapy is vital for proper sepsis treatment. Overflowing ERs are directly associated
with reducing quality performance measures (Gaieski et al., 2017).
Concluding the literature review, implementing nursing and provider education is
warranted to maintain high-quality care regarding sepsis treatment modalities and timely IVF
resuscitation. Therefore the DNP project focused on improving the initiation of IVF resuscitation
in septic and septic shock adults in the ER. This literature review aided in developing the project
PICO(t) question and the study’s methodology construction.
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Theoretical Framework
Kurt Lewin’s theory of planned change guided the development of this DNP project.
Translating transformations within groups, systems, or health initiatives, Lewin recognized
change as constant stemming from driving and opposing forces. These forces evolve into three
stages: unfreezing, moving, and refreezing. Unfreezing assesses the need to educate teams to
move towards improvement in practice (Zaccagnini & White, 2017). Moving motivates teams to
accept and implement improvement, minimizing barriers to change. Refreezing provides
safeguards to allow for the continuation and maintenance of desired change. Lewin believed
individuals could reform their perceptions by conflict resolution and understand processes
through planned change and learning (Zaccagnini & White, 2017).
Methodology
The DNP project aimed to improve nurse adherence and timely IVF resuscitation in
septic adults in a rural ER. Retrospective chart reviews were performed of sepsis data in
December 2021 and again in mid-February through mid-March 2022. The project’s intervention
included staff education about the importance of rapid initiation and minimizing delays in IVF
resuscitation treatment. Nurses in the ER were provided a pre-test questionnaire and educated on
the Hour-1 bundle protocol from the Surviving Sepsis Campaign. The emphasis of teaching was
placed on minimizing delays in starting IVF resuscitation. After educational instruction, a posttest questionnaire was completed, followed by a retrospective chart review post-intervention to
evaluate the impact of the teaching intervention. A return folder was placed in the break room
and secretary station to maintain anonymity. Education sessions were provided mid-shift as a
conversation between the nurses and the principal investigator (PI). Nurses were provided an
educational flyer on the Hour-1 Initial Resuscitation for Sepsis and Septic Shock Surviving
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Sepsis Campaign (Society of Critical Care Medicine & European Society of Intensive Care
Medicine, 2019).
Setting
The DNP project occurred in an acute care ER at a non-profit hospital in rural northwest
Georgia. The hospital is designated a Level III trauma center and a Level I emergency cardiac
center for care. Including the triage area, the ER has 24 beds, two of which are designated as
trauma bays. The ER also provides a functioning helipad to assist in air ambulance transport of
critically ill patients. Over the past two years, the ER has treated approximately 700 to 800
patients weekly.
Population
The population of interest was ER nurses caring for adult sepsis and septic shock
patients. Participants included full-time, part-time, and per diem day shift nurses holding
permanent and travel positions. Of the 21-dayshift nurses, 13 participated in the study and were
included in the project’s sample size.
Inclusion and Exclusion Nursing Criteria
Inclusion criteria for this DNP project included day shift registered nurses working in the
ER as permanent hospital employees or contract agency nurses. During the post-implementation
chart review, severe septic and septic shock patient charts were not eliminated from the analysis
based on whether the nurse participated in the teaching session. The analysis included patient
chart reviews that met severe septic and septic shock parameters. Exclusion criteria included
nightshift nurses. Also excluded from the study were physicians, advanced practice providers,
unit administrators, and ancillary staff.

22
Recruitment and Consent
ER nurses were asked to participate in an anonymous DNP student-led project and
informed of the consent, pre-assessment questionnaire, and teaching, followed by a postassessment questionnaire. Consent forms were attached to the questionnaires and completed
before participation (see Appendix A). The consent forms emphasized the DNP project as
student-led to improve IVF resuscitation treatment time in septic and septic shock patients. The
consent form further explained the privacy and confidentiality of collected data, maintained in a
secured folder with only the principal investigator having access.
Design
The design of this DNP project was for quality improvement of sepsis treatment through
nursing education based on evidence. Institutional Review Board (IRB) approval was obtained
before the start of the student lead DNP project (see Appendix J). This DNP project utilized ER
dayshift nurses who took a pre- and post-questionnaire through convenience sampling and
retrospective data sampling to evaluate IVF resuscitation times of sepsis and septic shock
patients. Nurses were provided a pre-assessment questionnaire to determine a baseline of
knowledge based on Likert scale-designed questions. Nurses were educated face-to-face after
pre-assessment questionnaires were collected. The post-test questionnaires were administered to
evaluate data pre- and post-intervention.
The PI conducted teaching sessions and provided nurses with a Surviving Sepsis
Campaign flyer that coincided with the concepts of questionnaires. The questionnaires included
the following questions about the nurse’s ability to: (a) identify all five (5) Surviving Sepsis
Campaign (SSC) hour-1 care bundle elements, (b) identify SIRS criteria, (c) identify the
timeframe in which IVF resuscitation should begin and end once sepsis is identified, and IVF
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resuscitation ordered, (d) identify the correct amount of IVF to administer per individual patient
based-off set criteria of at least 30mL/kg once sepsis-induced hypoperfusion or septic shock has
occurred, and (e) understand the importance of acting quickly and minimizing delay in treatment
of sepsis and septic shock patients (Society of Critical Care Medicine [SCCM] & European
Society of Intensive Care Medicine [ESICM], 2021).
DNP project committee members evaluated the questionnaire. The PI developed a Likertstyle questionnaire with content based on the Surviving Sepsis Campaign flyer, which was
discussed with the prior Sepsis Coordinator, who is now an assistant manager in the Emergency
Room (ER). Evaluation and vetting also included discussions with the DNP project chair and
preceptor. Nurse practice timing was assessed through an additional retrospective sampling of
patients for approximately five weeks (37 days) in February and March post-intervention to
compare IVF resuscitation initiation times.
Chart Reviews
Upon IRB and hospital approval, a retrospective pre-intervention chart review
commenced in the sepsis coordinator’s office utilizing sepsis protocol data from December 2021.
The study reviewed 142 charts with 67 septic and septic shock patients identified. Charts were
identified by a consult order placed to the sepsis coordinator when SIRS criteria alerted a patient
that may be septic. Chart reviews determined the time of patient arrival, triage time, sepsiscoordinator consult time, and time of IVF fluid resuscitation administration. This data was
compared against the recommended evidence-based practice by CMS for hospital fallouts.
Twenty-five out of 67 (37.3%) fallouts were identified.
Data was collected from the rural Northwestern Georgia acute care hospital using
Meditek; this was the only electronic medical record (EMR) system utilized in data collection for
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this DNP project. Emergency Room (ER) post-intervention retrospective data collection started
the week after teaching sessions in mid-February and continued for approximately five (5) weeks
(37 days) into March 2022. Age and sex were the only identifiable patient data collected from
the EMR, as all other patient data was un-identified for this study. No identifiable data was
included in the analysis or contents of this DNP manuscript. The PI and hospital quality control
personnel who aided in data collection were the only researchers involved in data retrieval. The
PI created pre- and post-intervention tables (see Appendix B and E). Both pre- and postintervention tables of patient chart review included information about: (a) patient age/sex, (b)
type of sepsis, (c) time of arrival, triage, and sepsis coordinator consult, (d) pertinent labs or
vitals, (e) IVF start time, (f) admission and discharge date, (g) reason for admission, (h) weight,
the total volume of IVF received, (i) miscellaneous information or reason for fallout, (j) minutes
until IVF start time, and (k) length of stay.
Risks and Benefits
Observance of autonomy, beneficence, non-maleficence, and justice were applied to
uphold fundamental ethical standards for protecting patient and nurse data. Maintaining the
confidentiality of retrospective, interventional, and prospective data was the most significant
concern for the PI. A potential breach of confidentiality was mitigated by the PI’s assurance of
data security by preserving anonymity. Benefits included improved patient outcomes by
implementing high-quality nursing care standards in treating sepsis and septic shock patients.
Enhanced patient care will benefit the hospital by minimizing costly admissions, improving
hospital length of stay, and decreasing patient mortality.

25
Timeline
IRB approval was granted on December 9, 2021. Pre-intervention chart reviews occurred
in December 2021, followed by initial data organization and analysis. Project intervention
followed, including questionnaires with education in mid-February 2022. Post-intervention chart
reviews occurred from the last week of February through March 2022, including final data
organization and analysis (see Appendix C).
Budget and Resources
The DNP project received no external funding to aid in project completion, with expenses
costing the PI under one hundred dollars to complete (see Appendix D). The PI budgeted costs
between five-nine hundred dollars for anticipated project completion. However, the only cost to
the PI was the material printing at an estimated cost of ten dollars.
Evaluation Plan
Statistical Considerations
Pre-intervention retrospective data collection included calculating descriptive statistics by
frequency (%) of proper IVF resuscitation times. Post-intervention data collection included
calculating descriptive statistics by frequency (%) of appropriate IVF resuscitation times.
Fisher’s exact statistical test was utilized to compare IVF resuscitation times before and after the
educational intervention for nurses. Efficacy was analyzed through pre-and post-questionnaires
using the Wilcoxon signed-rank test to compare data using Likert scale style question results of
nurses who consented to participate in the DNP project. The principal investigator coded all data
to maintain confidentiality and analyzed using a statistical software package.
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Data Maintenance and Security
Nurse questionnaires were differentiated by permanent hospital staff and travelers
identified by the participant. A comparison of pre- and post-questionnaire responses was then
performed. Questionnaires were maintained confidentially by excluding identifying information
and kept in a closed survey collection folder. Nurse questionnaires and patient data were kept onsite in a locked office to maintain confidentially. Upon final manuscript completion, all data used
in the analysis remained un-identified in the manuscript to maintain the confidentiality of
participants and patients. According to the recommended Jacksonville State University (JSU)
ethical study guidelines and the Collaborative Institutional Training Initiative (CITI) program
completion (see Appendix I), all DNP project data was destroyed. Nurse participation and patient
data did not leave the hospital campus in compliance with the ethical standards of hospital policy
of student study conduct and per national HIPAA guidelines.
Results
This section will highlight data collection and analysis results, including quantitative data
from pre and post-intervention retrospective chart reviews and pre- and post-intervention nurse
assessment questionnaires. Specific highlights will include: (a) pre-intervention IVF resuscitation
time results for sepsis and septic shock patients versus post-intervention and (b) pre-intervention
nurse knowledge of sepsis and septic shock treatment versus post-intervention.
Results of Chart Reviews
Pre-intervention retrospective chart reviews revealed 142 consults for sepsis. Of those
142 consults, 67 reviewed cases included the following: (a) 41 severe sepsis cases, (b) 19 septic
shock cases, and (c) seven (7) cases unable to be specified due to incomplete patient results. The
additional 75 consults of the 142 were excluded from data analysis as they did not meet the
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project study criteria. Of the 142 consulted and reviewed cases, 37.3% (25) fell out of evidencebased practice criteria in meeting IVF resuscitation treatment time for severe sepsis and septic
shock. To further examine and highlight project data results, IVF resuscitation delay was further
divided into cases of severe sepsis (16/41 = 39%), septic shock (5/19 = 26.3%), and unspecified
(4/7 = 57.1%) (see Appendix B).
The retrospective post-intervention chart reviews revealed 38 consults for sepsis. Of
those 38 consults, 19 reviewed cases included the following: (a) 13 severe sepsis cases, four (4)
septic shock cases, and two (2) cases unable to be specified due to incomplete patient results.
The additional 19 consults of the 38 were excluded from data analysis due to only meeting SIRS
sepsis criteria. Of the 38 consulted and reviewed cases, 36.8% (7) fell out of evidence-based
practice recommendations in meeting IVF resuscitation treatment times for severe sepsis and
septic shock. Severe sepsis (6/13 = 46.2%) and septic shock (1/4 = 25%) cases continued to
present a delay in IVF resuscitation as noted (see Appendix E). There was minimal improvement
in IVF resuscitation initiation times, with pre-intervention at 37.3% and post-intervention at
36.8%, a minimal difference of 0.5% time improvement.
Due to a relatively small number of participants, Fisher’s exact test was utilized to
determine a nominal variable’s nonrandom proportions compared to another nominal variable’s
value (Weisstein, 2022). The resulting probability (p-value) corresponded to the number of
variables assumed to be greater than or equal to the observed results (Bind & Rubin, 2020).
Fisher’s exact test was performed, revealing results not statistically significant with a p-value =
1.00 (higher than the significance level ≥ 0.05). Comparison groups included IVF administered
on time versus IVF administered outside a 60-minute time frame in pre- and post-intervention
teaching outcomes. Appendix B and E include information on timely IVF administration times
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(denoted in black in the charts) versus fallouts of more than 60 minutes (denoted in red in the
charts). The following Fisher’s Exact Test table was completed using the statistical package for
the social sciences (SPSS) software:
Table 1: Fisher’s Exact Test

CHART AUDIT of
Timely IVF
Resuscitation
Initiation
CHART AUDIT of
Fallout IVF
Resuscitation > 60
Minutes
TOTALS

Pre-Intervention
Teaching

Post-Intervention
Teaching

TOTALS

42

12

54

25

7

32

67

19

86

Results of Questionnaire Responses
Thirteen dayshift nurses were surveyed through convenience sampling with one hundred
percent of pre-and post-intervention questionnaires completed. One hundred percent of
questionnaires were completed by participants consenting to participate in the study. All five
questionnaire statements were Likert-style rated questions, assessing nurses’ knowledge of
sepsis-related treatment topics.
After pre-intervention questionnaires were completed (see Appendix F), nurses were
educated face-to-face using the Hour-1 Bundle Surviving Sepsis Campaign Flyer (Society of
Critical Care Medicine & European Society of Intensive Care Medicine, 2019) and an
educational teaching session form (see Appendix H). After education, a post questionnaire (see
Appendix G) was administered. Questionnaire answers were compared and analyzed to
differentiate the scored ranks of ER nurses using non-parametric statistical hypothesis testing
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through the Wilcoxon signed-rank test (Sylvia & Terhaar, 2018). The following Wilcoxon
signed-rank test table was completed using SPSS software:
Table 2: Wilcoxon Signed-Rank Test
Question
1. I can identify all five (5)
Surviving Sepsis Campaign
(SSC) hour-1 care bundle
elements.
2. I can identify SIRS criteria.
3. Once an initial screening for
sepsis is complete and IVF
resuscitation orders have been
received, I can identify the
timeframe in which IVF
resuscitation should begin and
end?
4. Once sepsis-induced
hypoperfusion or septic shock
occurs, I can identify the correct
amount of IVF to administer per
individual patient based on the set
criteria of at least 30 mL/kg?
5. I understand the importance of
acting quickly and minimizing
delays in treating sepsis and
septic shock patients?

Scale

W(- Sum
rank)

W+
(+ Sum
rank)

p-value

1 (Never)
to
5 (Always)

0

45

0.004

1 (Never)
to
5 (Always)

0

3

0.003

1 (Never)
to
5 (Always)

0

0

0.317

1 (Never)
to
5 (Always)

0

15

0.037

1 (Never)
to
5 (Always)

0

1

0.037

Questionnaire response one evaluated the nurses’ ability to identify all five Surviving
Sepsis Campaign (SSC) hour-1 care bundle elements, including the following: (a) measuring
lactate levels, (b) obtaining blood cultures before antibiotic administration, (c) administering
broad-spectrum antibiotics, (d) beginning rapid administration of 30 mL/kg of crystalloid IVF
for hypotension or lactate levels greater than or equal to 4 mmol/, and (e) the administration of
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vasopressors if hypotension during or after IVF resuscitation occurs to maintain a mean arterial
pressure (MAP) of greater than 65 mmHg. Using the Wilcoxon signed-rank test, response one
revealed a positive-sum rank of 45 compared to the negative sum rank of 0, with a p-value =
0.004. Scores were higher post-intervention, indicating an increase in nurses’ ability to identify
hour-1 care bundle elements.
Questionnaire response two evaluated nurses’ ability to identity SIRS criteria, including
the following: (a) fever > 100.4 or hypothermia < 96.8; (b) tachypnea > 20 breaths per minute;
(c) tachycardia > 90 beats per minute; and (d) leukocytosis > 12,000, leukopenia < 4,000, or
bandemia > 10% bands. Using the Wilcoxon signed-rank test, response two revealed a positivesum rank of 3 compared to the negative sum rank of 0, revealing a p-value = 0.003. Scores were
higher post-intervention, indicating an increase in nurses’ ability to identify SIRS criteria.
Questionnaire response three evaluated nurses’ ability to identify the timeframe in which
IVF resuscitation should begin (within one hour or as soon as possible) and end (three hours).
Using the Wilcoxon signed-rank test, response three revealed a positive-sum rank of 0, equal to
the negative sum rank of 0 with a p-value = 0.317. Scores were the same pre- and postintervention, indicating no significant increase in nurses’ ability to recognize IVF resuscitation
timeframes.
Questionnaire response four evaluated nurses’ ability to identify the correct amount of
IVF to administer per individual septic patient based on the set criteria of 30 mL/kg. Using the
Wilcoxon signed-rank test, response four revealed a positive-sum rank of 0 compared to a
negative-sum rank of 15, with a p-value = 0.037. Scores were higher post-intervention,
indicating an increase in nurses’ ability to identify the correct amount of IVF to administer per
individual septic patient based on the set criteria of 30 mL/kg.
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Questionnaire response five evaluated nurses’ ability to identify and recognize the
importance of rapid severe sepsis and septic shock treatment through the hour-1 bundle
recommendations. Using the Wilcoxon signed-rank test, question five revealed a positive-sum
rank of 0 compared to a negative-sum rank of 1, with a resulting p-value = 0.037. Scores were
higher post-intervention, indicating an increase in nurses’ ability to identify and recognize the
importance of rapid severe sepsis and septic shock treatment. Examples of the hour-1 bundle
include: (a) measuring lactate level (re-measuring if initial lactate elevated >2 mmol/L), (b)
obtaining blood cultures before antibiotic administration, (c) administering broad-spectrum
antibiotics, (d) beginning rapid administration of 30 mL/kg crystalloid for hypotension or lactate
greater than or equal to 4 mmol/L, and (e) utilizing vasopressors if hypotension ensues during or
after IVF resuscitation to maintain a mean arterial pressure (MAP) greater than or equal to 65
mmHg (Society of Critical Care Medicine & European Society of Intensive Care Medicine,
2021).
Discussion
This DNP project sought to improve the time-sensitive administration of IVF
resuscitation in adult patients diagnosed with sepsis or septic shock. The project’s overall aim
was to enhance ER nurses’ end-user knowledge of and adherence to evidence-based sepsis
treatment recommendations over approximately five (5) weeks (37 days). Quantitative data was
utilized to measure the project’s capacity to meet the overall aim.
Statistically significant findings included survey questions 1, 2, 4, and 5, with a p-value
<0.05 revealing proper understanding and increased knowledge after teaching for appropriate
sepsis treatment times regarding IVF resuscitation. In the literature review, IVF resuscitation
times were not studied as comprehensively as the ‘golden hours’ of antibiotic administration
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despite agreements on the adverse effects of sepsis disease progression regarding hypoperfusion
and hypoxemic states as a result of delayed IVF resuscitation (Leisman et al., 2016). Many
studies suggest a decrease in mortality when IVF resuscitation is initiated rapidly. Although
generalizable, adherence to rapid IVF initiation time and decreasing delays in treatment likely
play a significant role in patient survival (Leisman et al., 2016). Study results from Leisman et al.
(2016) also suggested that conservative intervention times like the 3-hour and 6-hour bundle
guidelines are delayed timeframes for proper treatment of sepsis, with evidence leaning more
towards a 30-minute IVF resuscitation initiation timeline (Leisman et al., 2016).
Nurses were extremely busy in the ER. Therefore, education was performed quickly to
decrease interruptions with unit tasks. The majority of nurses included in the study were open
and accepting of teaching but did not keep the educational material provided and did not ask
many questions or offer opinions on how to improve IVF resuscitation times regarding the
protocol. The DNP project revealed that chart reviews were not statistically significant, with a pvalue = 1.0; however, to determine the effect of the sample size, a power analysis would need to
be conducted, but an analysis of power to detect an effect was not performed in this study. The
pre- and post-intervention retrospective chart review revealed a difference in IVF resuscitation
start times of 0.5%, which improved initiation. Although not statistically significant, the PI
inferred that more time and in-depth education for ER nurses would yield a more substantial
difference in IVF resuscitation times, signifying treatment improvement and further minimizing
delays.
Implications
The retrospective chart review did not yield the desired delay decrease in IVF
resuscitation times. Regardless, variations in recommended clinical practice guidelines on
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treatment standards create potential risks or, in worse cases, harm to the patient (Bradshaw &
Vitale, 2021). IVF resuscitation initiation time within 30 minutes of sepsis presentation is
associated with improved hospital length of stay and patient mortality, resulting in an easier
performance predictor of sepsis and septic shock time management than IVF completion time
(Leisman et al., 2016). Mortality was decreased by 5%, and length of stay decreased by one day
in IVF resuscitation times less than 30 minutes (Leisman et al., 2016). The Surviving Sepsis
Campaign standardization of bundle completion advocates for lactic acid, blood cultures, broadspectrum IV antibiotics, and IVF resuscitation (30mL/kg) within 180 minutes of sepsis
recognition (Leisman et al., 2016).
Though hospital policies exist for sepsis treatment protocols, diligence is necessary to
maintain high proper treatment standards for patients suffering from sepsis. There is room for
improvement in sepsis bundle components, particularly in initiating treatment times across
bundle components (IVF resuscitation and antibiotic start times, drawing cultures before IV
antibiotics). Quality implications for safety are also imperative for proper patient care. Rapid
treatment of the body’s inflammatory cascade is known to improve patient outcomes of mortality
and length of stay, shedding light on sepsis as an emergency (similar to myocardial infarction or
stroke) that prioritizes decreasing treatment time to improve a patient’s chance of survival.
Limitations
This DNP project has several limitations. For one, the size of this project is relatively
small. Relating to the size of the project, the hospital is relatively small, and the unit of study was
small to include a small sampling of nurses. The project’s timeline was also a limiting factor,
spread over five weeks. The study also only looked at the time of initiation as a factor of interest;
it did not consider the volume of fluid resuscitation patients received.
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Additionally, chart reviewing (as mentioned in the inclusion and exclusion) included
severe sepsis and septic shock patients post-intervention during the specified time frame. Charts
were not eliminated from the analysis based on whether a nurse participated in the study
questionnaire and teaching. The IVF resuscitation timing chart review included severe sepsis and
septic shock patients.
Other limitations included significant hospital changes during the study, selling to
another company with transitions to new tracking systems for core measures. The Sepsis
Coordinator position also had changed with new personnel to the role that then resigned followed
by a period of absence, followed by the rehiring of new personnel, which affected the original
plans for data collection.
During the initial chart review, the hospital saw a significant increase in the patient
census with the additional wave of COVID-19 variants. The ER felt the stress of higher census
straining the nursing staff. The ER also has seen an increase in travel agency nurses, although
this did not affect the survey as none of the travelers opted to participate in the DNP project. The
PI was employed as a bedside nurse at the facility and worked alongside the staff in the ER,
which may have contributed to bias in participation and filling out survey questions.
Dissemination
The dissemination of this research study and DNP project titled: Improving Intravenous
Fluid Resuscitation Compliance of Sepsis and Septic Shock Adults in a Rural Emergency Room
is available in the Jacksonville State University (JSU) Digital Commons repository. The DNP
project was completed through a written manuscript, presented via poster, and through the
University’s Virtual Dissemination Day.
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Plans for Future Scholarship
This project was conducted to add continuing data to support and stress the importance of
following evidence-based research in treatment and protocol development for patient care.
Further research is needed to expand and continue to shed light on the importance of minimizing
delay in severe sepsis and septic shock treatment. Future studies need to identify reasons for
treatment delay times and address each fallout that occurs in the bundle, such as administration
of antibiotics before drawing blood cultures, delay in initiation of antibiotics, lack of
documentation, and delay in initiation of vasopressors if needed. Tracking specific trends with
each nurse may also be beneficial in future studies to pinpoint exactly where a delay occurs and
offer further education to individuals needing specific support. Efforts to study the purpose of
delays may aid in minimizing issues surrounding sepsis care and could also be beneficial in
helping nurses streamline and increase treatment time.
The organization should also conduct efforts to maintain good staffing ratios during
pandemic times and retain the position of Sepsis Coordinator. This coordinator provides the
benefits of continuous surveillance and monitoring of issues surrounding treatment for sepsis
protocol. Increasing the size of the project/study to include the initial triage of sepsis patients and
involving physicians and management could also yield more significant results in the future.
Implementation longevity is another area to address, as this DNP project was limited to a
semester (three to four months). Larger sample sizes with a more extensive timeframe would
likely yield more significant results.
Sustainability
Since sepsis is a monitored quality measure through the CMS, the sustainability of
protocol implementation for sepsis continues to be monitored and surveyed by hospital
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personnel. Future nurses can aid in implementing hour-1 or fewer bundles to improve sepsis
treatment times. Prospective studies similar to the DNP project could also be addressed in other
hospital care areas to evaluate initiation times across the organization.
Conclusion
Early IVF resuscitation is imperative in stabilizing tissue hypoperfusion induced by
severe sepsis or septic shock. Due to the urgent and emergent nature of the body’s rapid decline
from sepsis, initial treatment of sepsis bundles, including IVF resuscitation, should begin
immediately upon identification of hypotension and lactic acidosis when sepsis is suspected or
diagnosed (Levy, Evans, & Rhodes, 2018). Fallouts from inadequate sepsis protocol bundles still
occur, as evidenced by the assessment of IVF resuscitation times during this project. This study
sought to bring awareness to the need for improvement, especially during pandemic times when
ERs see higher volumes of patients. Nurses play a crucial role in the timing and coordination of
care regarding sepsis treatment. Standardization through sepsis bundle protocol can aid in lifesaving measures; however, they must be followed accordingly. More in-depth research should be
conducted in the ER and other patient care areas to identify and eliminate barriers preventing
proper care to avoid future failures in sepsis protocol treatment.
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Appendix A
Participant Consent Form
Title of Project Study:
Improving Intravenous Fluid Resuscitation Compliance of Sepsis and Septic Shock Adults in a
Rural Emergency Room
This form provides informed consent for a doctor of nursing practice (DNP) student-led project.
This consent form provides project information to help you decide whether you wish to
participate voluntarily or opt out. If you wish to participate, please complete the attached preintervention questionnaire and participate in the associated educational session to be provided.
Why is this project being implemented?
This project aims to improve timely IVF resuscitation in septic patients through increased nurse
adherence to sepsis treatment through Hour-1 evidence-based practice.
What will project participation entail?
The project will survey nurse knowledge regarding sepsis Hour-1 bundle protocols regarding
IVF resuscitation through the administration of pre-intervention questionnaires and the
implementation of educational teaching sessions. Education will be face-to-face, with
participants completing post-intervention questionnaires after educational implementation.
What are the potential risks involved with project participation?
No harm or cost will incur from project participation. This project will have no influence from or
involvement of upper management. Again, participation is entirely voluntary.
What measures will be taken to ensure privacy and confidentiality?
Each participation questionnaire will have a randomized ID code with no other identifiable
personal information. Questionnaires will remain in a locked office within the project setting
through project completion.
What are the stipulations for project withdrawal?
You may choose to withdraw participation at any time. If you have any questions about the
project participation, please call the principal investigator (PI), Alison Douglas, at (407) 7827139 (cell). Withdrawal of consent must be completed in writing to Alison Douglas (PI) at
adouglas3@stu.jsu.edu.

Signature: ______________________________________ Date: ___________________

42
Appendix B
Pre-Intervention Retrospective Chart Reviews (December 2021)
#

Age
Sex

Sepsis Type

Arrival time
Triage time
Consult time

1

39
M

Severe

1304
1325
1452

2

61
M

Severe

0100
0111
0109

Labs
Vitals
LA: 2.35 @1429
0.5 @1645
HR 133
Hypotension?
LA: 1.34 @0130
1.08 @0326
Crt 8.66
T: 103.3
HR 91
RR 21
Hypotension?
LA: 1.22 @ 0048
WBC 22.3
Crt 2.76
HR 98
Hypotension?
LA: 2.61 @2033
2.6 @2219
WBC 19.4

IVF
start
time

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.

Min. to
IVF

LOS
(Days)

1448

12/23 – 12/27
Abscess
108.9 kg/NS 4300mL

83 m

4D

0333

12/7 – 12/25
AMS/PNA/ESRD/Hypoxia/on
HD
No weight/NS 500mL

142 m

18 D

22 m

18 D

27 m

3D

NA

14 D

59 m

9D

NA

4D

114 m

4D

NA

6D

31 m

3D

NA

2D

NA

4D

NA

2D

3

54
M

Severe

1730
1745
2012

4

66
F

Severe

2007
2045
2112

5

89
M

Severe

0907
0915
0931

LA: 1.91 @0941
WBC 14.9
Crt 2.27
HR 108
RR 24

NA

6

56
F

Severe

1908
1916
1930

LA: 2.9 @1920
1.5 @0506
HR 93

2015

7

66
F

Severe

1632
1635
1654

8

66
M

Severe

0056
0101
0255

LA: 2.18 @2023
2.6 @2159

NA

LA: 2.41 @1651
1.2 @1855
HR 99
RR 28
LA: 1.41 @0246
Crt 5.81
HR 113
RR 20

1807

2112

NA

0255

9

78
F

Severe

1615
1623
2005

10

88
F

Severe

0852
0915
0921

LA: 2.76 @0937
2.0 @1150

0946

11

76
F

Severe

0430
0432
NA

LA: 3.01 @0450
1.5 @0655
HR 101
RR 36

NA

12

67
F

Severe

1025
1037
1211

LA: 2.59 @1114
1.8 @1348

NA

13

74
M

Severe

0847
0854

LA: 1.64 @ 0930
WBC 13.2

NA

12/7 – 12/25
AKI/UTI
113.6 kg/NS 2000mL
FALLOUT: ON ALL OTHER
BUNDLE TIMES
12/22 – 12/25
Ax. Cholecystitis
No weight/NS 500mL
12/9 – 12/23
Respiratory failure w/ hypoxia,
CHF/COPD
Exacerbation/BIPAP
82.5 kg/No IVF
FLUID OVERLOADED
12/14 – 12/23
COVID/PNA/hypoxemia
109.1 kg/NS 3330ml (received
2L)
ANTIBIOTICS BEFORE CNS
12/19 – 12/23
Pulmonary edema/Acute
hypoxic respiratory failure
138.6 kg/NO IVF
12/18 – 12/22
Severe esophagitis/SIRS
75 kg/NS 500 mL
12/16 – 12/22
Cellulitis/Hypoxia
69 kg/NO IVF
FALLOUT: NO MENTION
OF SEPSIS/NO 1 OR 3 HR.
BUNDLE
12/18 – 12/21
AMS/Acute lactic
acidosis/Acute, chronic
respiratory failure
79.6 kg/NS 1000mL
12/19 – 12/21
Acute on Chronic respiratory
failure w/ hypoxia
68.2 kg/NO IVF
12/17 – 12/21
AMS/UTI/Hx. Kidney
transplant
100 kg/NO IVF
12/19 – 12/21
PNA/ESRD on HD

43
0921

Crt 5.92
T 100.0, HR 91

76.8 kg/NO IVF

Sepsis Type

Arrival time
Triage time
Consult time

Labs
Vitals

IVF
start
time

Severe

1111
1117
1215

LA: 3.68 @1220
3.4 @1429
WBC 21.8
Crt 2.10
HR 109

1205

#

Age
Sex

14

88
M

15

63
F

Severe

1130
1141
1311

16

70
F

Severe

1331
1336
1349

17

65
M

Severe

2359
0002
0019

18

64
M

Severe

2132
2152
0041

19

56
F

Severe

1624
1627
1630

20

65
M

Severe

1507
1514
1520

21

82
M

Severe

1823
1828
1930

22

64
M

Severe

1721
1730
2344

LA: 2.69 @0006
1.7 @0100
HR 108

2342

23

20
F

Severe

1729
1732
1737

LA: 3.41 @1740
T 100.3
HR 166

1907

24

51
F

Severe

1658
1702
1720

LA: 0.52 @1832
HR 102
RR 30

NA

25

69
F

Severe

1910
1922
1924

2036

26

77
M

Severe

1232
1239
1306

LA: 2.02 @1937
2.2 @2113
T 102.0
HR 111
LA: 2.68 @1257
2.6 @1455

NA

27

90
F

Severe

1603
1608
1617

LA: 2.21 @1625
1.6 @1802
Bili 2.7 @1610
HR 138

NA

LA: 1.72 @1358
WBC 45.2
Crt 2.14
RR 20
LA: 2.40 @1359
1.4 @1549
WBC 15.5
Crt 3.09
HR 146
LA: 2.34 @0019
1.7 @0215
HR 129
LA: 2.04 @2337
1.49 @0015
HR 94
RR 20
LA: 2.8 @1639
1.1 @1825
WBC 18.9
HR 104
RR 30
LA: 2.18 @1536
1.4 @1744
Bili 5.4
HR 128
RR 20
LA: 2.09 @1941
1.9 @2200
WBC 19.8
HR 100

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.
12/14 – 12/21
Vomiting/RUQ
inflammation/GIB
84 kg/NS 2000 mL
FALLOUT ANTIBIOTICS
BEFORE CULTURE

Min. to
IVF

LOS
(Days)

48 m

7D

1338

12/4 – 12/20
Acute Rhabdo s/p fall/AKI
104.5 kg/NS 500 mL

117 m

16 D

1411

12/14 – 12/19
AMS/AKI/NSTEMI/Afib RVR
78.9 kg/NS 2400 mL

35 m

5D

0039

12/13 – 12/18
PNA/Hypokalemia/Fever
81.8 kg/NS 2500 mL

37 m

5D

2225

12/15 – 12/18
Acute pancreatitis
91.4 kg/NS 2000 mL

33 m

3D

NA

12/15 – 12/18
Hypoxia/Pneumonitis/COPD
No weight/No IVF

NA

3D

1602

12/12 – 12/17
Pancreatitis/elevated LFTs
110.4 kg/NS 3400 mL

48 m

5D

78 m

3D

360 m

3D

95 m

4D

NA

7D

74 m

4D

NA

10 D

NA

6D

1946

12/14 – 12/17
Acute diverticulitis/Sepsis/
Generalized weakness/Fall
92.3kg/NS 2800 mL
12/14 – 12/17
Acute right foot cellulitis/
Lactic acidosis
81.8 kg/NS 2000 mL
Triage time to IVF, all times
greater than 3 hours
12/12 – 12/16
SIRS/Tachycardia/Hypotensio
n/
Lactic acidemia
No weight/NS 1000 mL
12/9 – 12/16
Hypercapnic respiratory
failure/
PNA requiring BIPAP
151 kg
12/12 – 12/16
SIRS/Lactic academia
No weight/NS 1900 mL
12/5 – 12/15
Acute CHF exacerbation
88 kg/NO IVF
12/8 – 12/14
CHF exacerbation/new onset
Afib RVR
62.6 kg/No IVF
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Sepsis Type

Arrival time
Triage time
Consult time

28

62
M

Severe

2007
2013
0051

29

46
M

Severe

1018
1022
1031

30

62
F

Severe

0913
0913
0922

31

73
M

Severe

2236
2242
2346

32

47
F

Severe

1425
1430
1436

33

77
F

Severe

2143
2200
2319

Severe

0942
0947
1205

#

Age
Sex

34

75
M

35

71
F

Severe

1721
1817
1826

36

41
M

Severe

1506
1532
1556

37

29
M

Severe

0243
0251
0555

38

76
F

Severe

1828
1838
1841

39

64
F

Severe

1300
1311
1316

40

84
M

Severe

2338
2344
0004

41

68
M

Severe

1124
1128
1154

42

74
M

Shock

2223
2228
2239

Labs
Vitals
LA: 2.89 @0110
3.4 @0325
WBC 19.6
HR 104
RR 22
LA: 2.31 @1030
1.7 @1230
WBC 18.3
HR 138
RR 47
LA: 2.72 @0935
2.7 @1125
HR 119
RR 20
LA: 2.27 @2335
1.6 @0205
T 103.2
HR 93
RR 24
LA: 2.69 @1439
0.9 @1654
HR 100
RR 24
LA: 2.78 @2346
1.6 @0147
WBC 15.0
RR 20
LA: 2.3 @1213
1.9 @1344
WBC 3.8
HR 110
RR 24
LA: 3.96 @1852
2.9 @2142
WBC 12.6
HR 118
RR 30
LA: 2.35 @1610
1.4 @1528
Crt 9.38
HR 101
LA: 2.6 @ 0618
1.3 @0833
WBC 12.3
LA: 2.07 @1859
1.2 @2057
HR 126
RR 30
LA: 2.24 @1326
1.2 @1513
WBC 12.5
HR 136
RR 24
LA: 1.65 @0004
WBC 16.9
HR 96
LA: 2.49 @1147
2.1 @1323
WBC 12.2
T 101.3
LA: 2.98 @2303
2.5 @0146
Crt 3.27

IVF
start
time

NA

1037

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.
12/8 – 12/13
Ax on cx hypoxic respiratory
failure/COPD/CAPNA
WBC 19.6 @ 2035
59.1 kg/No IVF
12/6 – 12/13
Acute respiratory failure w/
hypoxia/multifocal
PNA/COPD
48.1 kg/NA 1500 mL

Min. to
IVF

LOS
(Days)

NA

5D

15 m

7D

0939

12/13 – 12/13
Orthostatic hypotension
No weight/NS 2000 mL

26 m

1D

2357

12/8 – 12/13
Sepsis/BLL PNA
122.7 kg/NS 50 mL
ORDERED NS 3700 ML

75 m

5D

1710

12/10 – 12/13
UTI/septic shock
86.3 kg/NS 1600 mL

160 m

3D

2244

12/7 – 12/10
Sepsis/AKI/ABD pain
89.1 kg/NS 1000 mL

44 m

3D

NA

2D

NA

6D

40 m

6D

250 m

1D

234 m

4D

18 m

3D

32 m

3D

26 m

3D

15 m

14 D

NA

NA

1612

0701

2322

1329

0016

1154

2243

12/6 – 12/8
Sepsis/PNA/New Afib RVR
70.9 kg/No IVF
ON CHEMO
FALLOUT: ANTIBIOTIC
TIME
12/1 – 12/7
Flash pulmonary
edema/NSTEMI
Required intubation
84.1 kg/No IVF
12/1 – 12/7
ESRD on HD/Fluid Overload
59.1 kg/NS 500 mL
12/5 – 12/6
Overdose
113.6 kg/NS 1000 mL
12/2 – 12/6
UTI/tachycardia
No weight/NS 1000 mL @
85mL/H
12/3 – 12/6
Severe sepsis/PNA/Acute
respiratory failure
41.7 kg/NS 1300 mL
12/2 – 12/5
Resp failure/CAP
WBC 16.9 @ 0053
81.1 kg/NS 2500 mL
12/1 – 12/4
Sepsis/PNA/CHF exacerbation
81.8 kg/NS 1000 mL
ORDERED 2500 mL
12/14 – 12/28
Severe sepsis/Respiratory
distress/UTI/Hypoxemia
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T 104.1
HR 102
RR 44
BP 65/50
#

Age
Sex

43

53
F

Sepsis Type

Arrival time
Triage time
Consult time

Labs
Vitals

IVF
start
time

Shock

0958
1004
1225

LA: 1.47 @1106
BP 76/47 @1004
BP 88/48 @1125
BP 88/56 @1322

1235

Shock

0232
0235
0300

Shock

1020
1028
1053

46

63
M

Shock

1317
1320
1328

47

29
M

Shock

1152
1206
1216

48

78
M

Shock

1157
1201
1230

49

64
M

Shock

1110
1115
1151

50

54
F

Shock

1327
1332
2030

44

68
M

45

64
M

51

63
F

52

45
F

90.8 kg/NS 500 mL
LEVOPHED @2354

Shock

1701
1708
1931

Shock

0920
0927
0926

LA: 1.61 @0243
1.05 @0900
WBC 18.2
Crt 3.02
BP 91/61 @0235
BP 83/66 @0300
BP 88/68 @0330
BP 89/56 @0420
LA: 1.62 @1051
Crt 3.65
RR 22
BP 80/43 @1028
BP 67/40 @1109
BP 91/68 @1149
BP 96/44 @1730
LA 6.49 @1331
5.1 @1532
T 100.0
HR 106
RR 26
LA: 10.78 @1203
HR 117
RR 20
LA: 13.64 @1210
12.1 @1415
WBC 15.1
Crt 2.10
RR 30
LA 2.44 @1143
T 100.6
HR 117
RR 28
LA: 5.35 @2104
5.34 @0036
HR 133
No BPs
LA: 6.59 @2035
9.0 @2224
Crt 2.30
T 103.6
HR 99
RR 24
BP 82/43 @1708
BP 74/38
BP 74/40
BP 75/41
BP 68/35 @1849
LA: 4.73 @0927
4.1 @1151
WBC 20.5
HR 120

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.
12/21 – 12/28
L. sternoclavicular
osteomyelitis/ Hx. of
cardiomyelitis
62.7 kg/NS 3000mL
LEVOPHED @?

Min. to
IVF

LOS
(Days)

151 m

7D

0317

12/17 – 12/27
Sepsis/Complicated
UTI/Ureteral stone/AKI
No weight/NS 1000 mL
LEVOPHED @0445

42 m

10 D

1102

12/20 – 12/25
Acute Encephalopathy
163.6 kg/NS 500 mL
LEVOPHED @?

34 m

5D

185 m

11 D

15 m

3D

66 m

3D

48 m

1D

20 m

2D

1730

12/6 – 12/18 (DECEASED,
DC TO HOSPICE)
AMS/Hepatic
encephalopathy/Pancytopenia
81 kg/NS 3000 mL
LEVOPHED @1708
FALLOUT: LATE LA

22 m

12 D

1006

12/11 – 12/18
Resp failure w/
hypoxia/Pulmonary
edema/PNA

39 m

7D

1625

1221

1307

1203

1352

12/14 – 12/25 (DECEASED)
COVID+/Respiratory failure
No weight/NS 1000 mL
FALLOUT: NO IVF GIVEN
W/I 3 HOURS
12/22 – 12/25
ABD pain/N/V
81.8 kg/NS 1000 mL
12/20 – 12/23
DKA
57 kg/NS 2000 mL
12/22 – 12/22
CP/COPD/SOB
121.9 kg/NS 1000 mL
ORDERED 3700 mL
12/18 – 12/20 (DECEASED)
Resp Failure/Metastatic breast
CA
66.4 kg/NS 2000 mL
LEVOPHED @1935
FALLOUT: ANTIBIOTIC
TIME, POOR TIME (@1841)
2ND IVF

46
RR 40
#

Age
Sex

Sepsis Type

Arrival time
Triage time
Consult time

53

49
F

Shock

1726
1801
2257

LA: 4.04 @2118
2.7 @2345
WBC 14.7
RR 22

2213

54

46
M

Shock

0652
0652
0659

LA: 9.85 @0700
4.6 @0907
WBC 14.5
HR 93
RR 20

0750

0955
1000
1010

LA: 6.76 @1013
3.7 @1218
HR 123
RR 31

55

56

57

58

59

79
F

80
M

64
M

62
M

84
F

Shock

Shock

0914
0915
1230

Shock

1938
1950
1957

Shock

0727
0730
0736

Shock

1409
1412
1424

60

75
F

Shock

1529
1552
1814

61

36
M

Unspecified

0144
0151
0202

Unspecified

0855
0902
0912

62

75
F

Labs
Vitals

IVF
start
time

LA: 4.14 @0930
2.5 @1205
Crt 4.25
T 101.9
HR 130
RR 26
LA: 1.21 @2001
0.60 @0433
Crt 4.25
RR 26
BP 72/36 @1950
BP 72/37 @2011
LA: 7.65 @0737
5.3 @0946
WBC 12.0
Crt 2.78
HR 115
RR 30
BP 91/54 @0730
BP 75/43 @0745
BP 88/47 @0800
BP 92/50 @0830
BP 80/42 @0845
LA: 4.50 @1425
2.9 @1603
HR 152
RR 36
LA: 3.58 @1552
3.5 @1759
WBC 14.6
Crt 3.30
Bili 3.4
HR 138
RR 32
LA: 2.12 @0156
@0.7 @0415
T 102.5
HR 101
LA: 3.70 @0931
4.7 @1123
WBC 22.1
HR 93
RR 22

No weight/NS 500 mL
Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.
12/13 – 12/16
Sepsis
126.6 kg/NS 3800 mL
FALLOUT: ALL TIMES,
TERMED SEPSIS IN ED
NOTHING ORDERED, ALL
TX ORDERED BY
HOSPITALIST

Min. to
IVF

LOS
(Days)

252 m

3D

12/9 – 12/16
Cardiac arrest/Respiratory
failure/PNA/Lactic acidosis
No weight/NS 2400 mL

58 m

7D

1328

12/12 – 12/16
Sepsis/PNA/Respiratory failure
w/ Hypoxia
No weight/NS 250 mL
FALLOUT: NO IVF FOR
SHOCK

208 m

4D

0940

12/8 – 12/14
Septic shock PNA
69.3 kg/NS 1000 mL
LEVOPHED @?

25 m

6D

12 m

9D

17 m

4D

18 m

2D

58 m

3D

2002

0747

1430

1650

12/4 – 12/13
AMS/Hypotensive/Severe
anemia
190.1 kg/NS 1000 mL
LEVOPHED @2033

12/9 – 12/13
Resp failure w/ hypoxia/Septic
shock/Persistent hypotension
No weight/NS 2400 mL
LEVOPHED @0904

12/7 – 12/9 (DECEASED,
HOSPICE)
New-onset Afib RVR/Lung
METS/Respiratory failure w/
hypoxia
52.7 kg/NS 1600 mL
12/2 – 12/5 (DECEASED)
Bil. PNA/Septic
shock/Hypotension
95.9 kg/NS 1000 mL
LEVOPHED @1904
FALLOUT: ANTIBIOTIC
TIMES

0219

12/23 – 12/29
Sepsis/UTI
63.6 kg/NS 1900 mL

28 m

6D

0911

12/24 – 12/29
Hypotension/PNA/Severe
sepsis/Septic shock
72.8 kg/NS 1000 mL
ORDERED: 2200 mL,

9m

5D

47
BP 75/51 @0900
BP 78/51 @0915
BP 83/50 @0930
BP 95/55 @1015
#

Age
Sex

NO VASOPRESSORS

Sepsis Type

Arrival time
Triage time
Consult time

Labs
Vitals

IVF
start
time

LA: 5.27 @2123
5.4 @2303
BP 94/48 @1828
BP 75/53 @1859
BP 86/59 @1946

1918

63

73
M

Unspecified

1752
1759
2102

64

47
F

Unspecified

0607
0610
0626

LA: 3.56 @0625
1.9 @0831
RR 40

NA

65

80
M

Unspecified

1035
1035
1343

No LA
T 100.2

NA

66

73
F

Unspecified

2110
2115
2331

No LA

0151

67

45
M

Unspecified

2104
2106
0058

No LA
RR 27

NA

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.
12/25 – 12/26 (DECEASED)
Pneumoperitoneum/Sepsis/Asc
ites/Malignant neoplasm
77.2 kg/NS 2000 mL
FALLOUT ANTIBIOTICS
BEFORE CULTURES
12/2 – 12/4
CHF/ESRD/Morbid obesity
185.9 kg/No IVF
12/25 – 12/26
Sepsis/PNA/Hypoxia
85.4 kg/No IVF
NO LACTIC ACID
12/6 – 12/13
AKI/PNA/Hypoxia/Hyperkale
mia
88.6 kg/NS 1000 mL
FALLOUT NO LA,
ANTIBIOTICS, & IVF, NO
1H/3H BUNDLE
12/7 – 12/8
Bronchitis/Hypoxia
166.8 kg
FALLOUT NO LA,
ANTIBIOTICS, & IVF, NO
1H/3H BUNDLE

Min. to
IVF

LOS
(Days)

79 m

1D

NA

2D

NA

1D

276 m

7D

NA

1D

48
Appendix C
Doctor of Nursing Practice (DNP) Project Timeline
Proposal
Develop.
Proposal
Approval
Support Letter
IRB(s)
Implementation
Data Collection
Data Analysis
Final Writing
Final
Presentation

GOAL!
JUN

JUL

AUG

SEP OCT
2021

NOV

DEC

JAN

FEB

MAR

APR MAY
2022

JUN

JUL
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Appendix D
Budget
PROGRAM EXPENSE
Salaries, wages (Admin support, practitioners,
statistics, or writing consultation)
Start-up costs (copies, charts, displays)
Poster printing
Final bound copy of the manuscript
Other: (Refreshments/incentive for teaching and
participation)
Total Project Expenses

PROJECTED
COST

ACTUAL
COST

Up to $500.00

$0.00

$100.00
$100.00
$200.00

$10.00
TBD
TBD

$100.00

$0.00

$500.00 - $900.00

$10.00
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Appendix E
Post-Intervention Retrospective Chart Reviews (February-March 2022)
#

Age
Sex

Sepsis
Type

Arrival time
Triage time
Consult time

Shock

1433
1435
1453

1

68
F

2

?
F

Severe

1923
1924
1938

3

?
M

Severe

1137
1139
1313

4

79
M

Severe

0911
0916
0923

5

?
M

Severe

1023
1025
1139

Severe

0426
0430
0433

6

?
F

Labs
Vitals
LA: 2.48 @1453
0.8 @1637
HR 117
RR 22
BP 69/44 @1530
BP 99/67 @1545
LA: 3.09 @1933
2.1 @2117
Crt 2.45
T 102.0
HR 96
LA: 2.9 @1322
3.3 @1552
WBC 19.0
Crt 4.19
LA: 4.73 @0933
3.47 @1115
T 94.6
Crt 2.36
BP 74/35
LA: 2.08 @1148
1.47 @1330
WBC 20.7
HR 138
LA: 3.79 @0433
6.4 @0630
WBC 16.4
Crt 13.20
RR 20
LA 12.58 @1000
11.27 @1125
WBC 13.6
Crt 3.17
T 92.7
HR 122
RR 24
LA 4.62 @1345
1.65 @1529
WBC 17.9
HR 125
RR 24
LA: 2.18 @1050
1.6 @1233
WBC 28.1
Crt 7.34
HR 105
RR 24

IVF
start
time

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.

Min. to
IVF

LOS
(Days)

1459

3/19 – 3/22 (HOSPICE)
Sepsis unknown
source/Hypotension
59.1 kg/NS 1700 mL

24 m

3D

143 m

2D

263 m
EXC.

10 D

2147

1602

0945

3/15 – 3/20
Severe sepsis/Hypovolemic shock
No weight/NS 2250 mL
LEVOPHED IN ED

29 m

5D

1040

3/16 – 3/18
Sepsis/Pneumonia/Afib RVR
No weight/NS 500 mL bolus

15 m

2D

0445

3/7 – 3/18
Metabolic & lactic
acidosis//ESRD/Hypokalemia
37 kg/NS 1500 mL
ANTIBIOTICS BEFORE
CULTURES

15 m

11 D

1010

3/13 – 3/17 (DECEASED)
Afib RVR (Cardioversion x2)
Hypotension/Hyponatremia/ARF
66.8 kg/NS & ½ NS volume?

88 m

4D

1305

3/12 – 3/17
Lactic acidosis/Leukocytosis/
Meningitis/Headache
120 kg/NS 2000 mL

44 m

5D

1305

2/25 – 3/10
AKI 2/2 septic shock
No weight/NS 2100 mL
DC TO REHAB

182 m

14 D

3m

21 D

101 m

2D

7

?
M

Severe

0826
0842
0846

8

?
F

Severe

1209
1221
1304

9

?
F

Shock

0954
1003
1030

LA 4.03 @1933
1.9 @2247
BP 75/42

1857

LA: 2.14 @1225
1.17 @1412
HR 123

1350

10

?
F

Shock

1857
1900
1911

11

79
M

Severe

1203
1209
1237

3/19 – 3/21
Sepsis unknown
source/Fever/Hypoxia/Lactic
acidosis/AKI
No weight/LR 1000 mL
3/11 – 3/21
AKI/Hyperkalemia/Sepsis/UTI/
Decubitus
No weight/NS 1000 mL
? DELAY DUE TO GOAL OF
CARE CONVERSATION, DC
TO HOSPICE

2/25 – 3/17
Septic shock/Hypovolemic/
Peritoneal dialysis/Recent COVID
No weight/NS 1400 mL
DC to REHAB
3/15 – 3/17
COPD Exacerbation/New A-fib
64.1 kg/NS 2000 mL

51
RR 30
Sepsis
Type

Arrival time
Triage time
Consult time

12

30
M

Unspec.

0720
0731
0730

13

?
M

Severe

1943
1959
2028

14

?
F

Severe

1543
1621
1638

15

?
M

Severe

1013
1030
1101

16

?
M

Shock

0817
0820
0842

17

?
M

Unspec.

0927
0932
0942

18

?
F

Severe

1425
1440
1514

19

?
M

Severe

1050
1103
1134

#

Age
Sex

Labs
Vitals
LA: 8.62 @0730
5.82 @0942
WBC 18.3
HR 95
RR 26
LA: 12.53 @2010
10.4 @2237
WBC 25.7
HR 140
RR 27
LA: 2.12 @1649
WBC 16.5
RR 25
LA: 2.46 @1055
1.9 @1314
HR 117
RR 28
LA: 2.07 @0858
2.3 @1044
WBC 22.1
T 99.1
BP 80/53
LA: 9.1 @0944
16.3 @1122
HR 138
RR 24
BP 72/32
BP 59/24
LA 2.3 @1445
3.5 @1720
WBC 12.5
T 99.4
HR 127
RR 24
LA: 2.22 @1117
1.2 @1309
WBC 12.8
T 100.8
HR 132
RR 27

IVF
start
time

Admit date – DC date
Admission Reason
Weight/IVF total (mL)
Misc.

Min. to
IVF

LOS
(Days)

0822

3/15 – 3/16 (DECEASED)
Overdose/Poly-substance
abuse/GCS 3
No weight/NS 1800 mL

51 m

1D

2054

3/7 – 3/15
DKA/AKI/Sepsis/Uremic acidosis
No weight/NS 2500 mL

55 m

8D

70 m

27 D

86 m

21 D

1731

1156

2/16 – 3/14 (DECEASED)
Acute on chronic respiratory
failure/COPD exacerbation/COVID
60 kg/NS 2000 mL
2/22 – 3/14
COPD/Sepsis/PNA/COVID/Acute
respiratory failure w/ hypoxia
56 kg/NS 250 mL

0904

2/28 – 3/14
Sepsis/UTI/Acute cystitis
No weight/NS 3400 mL

44 m

15 D

0953

3/3 – 3/14
Anaphylactic shock 2/2 to
Rocephin for bronchitis PNA
No weight/NS 3200 mL
LEVOPHED & EPINEPHRINE

21 m

11 D

1528

3/9 – 3/14
Sepsis/Pyelonephritis/
Hyperglycemia
92 kg/NS 2800 mL

48 m

5D

NA

3/10 – 3/14
Pneumonia/Sepsis
No weight/NO IVF
IVF NOT SCANNED, HOSP.
NOTE SAYS 1L IN ED?

NA

4D
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Appendix F
Quality Improvement Evaluation Pre-Intervention Questionnaire
ID Number: _______

Name: ________________________

Instructions: This questionnaire will evaluate individual nurses’ knowledge of sepsis and septic
shock treatment. Completion of this questionnaire will take approximately five (5) minutes.
Please read and answer each question. Answers will remain anonymous.
Please indicate one with a mark:

☐ I work as a hospital employee.
☐ I work as an agency employee.

1. I can identify all five (5) Surviving Sepsis Campaign (SSC) hour-1 care bundle
elements.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
2. I can identify SIRS criteria.
1
2
Never
Seldom

3
Sometimes

4
Usually

5
Always

3. Once an initial screening for sepsis is complete and initial IV fluid (IVF) resuscitation
orders have been received, I can identify the timeframe in which IVF resuscitation
should begin and end.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
4. Once sepsis-induced hypoperfusion or septic shock occurs, I can identify the correct
amount of IVF to administer per individual patient based on the set criteria of at least
30mL/kg.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
5. I understand the importance of acting quickly and minimizing delays in treating sepsis
and septic shock patients.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
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Appendix G
Quality Improvement Evaluation Post-Intervention Questionnaire
ID Number: _______

Name: ________________________

Instructions: This questionnaire will evaluate individual nurses’ knowledge of sepsis and septic
shock treatment. Completion of this questionnaire will take approximately five (5) minutes.
Please read and answer each question. Answers will remain anonymous.
Please indicate one with a mark:

☐ I work as a hospital employee.
☐ I work as an agency employee.

1. I can identify all five (5) Surviving Sepsis Campaign (SSC) hour-1 care bundle
elements.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
2. I can identify SIRS criteria.
1
2
Never
Seldom

3
Sometimes

4
Usually

5
Always

3. Once an initial screening for sepsis is complete and IV fluid (IVF) resuscitation orders
have been received, I can identify the timeframe in which IVF resuscitation should
begin and end.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
4. Once sepsis-induced hypoperfusion or septic shock occurs, I can identify the correct
amount of IVF to administer per individual patient based on the set criteria of at least
30mL/kg.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
5. I understand the importance of acting quickly and minimizing delays in treating sepsis
and septic shock patients.
1
2
3
4
5
Never
Seldom
Sometimes
Usually
Always
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Appendix H
Educational Session Resource
In December 2021, preliminary results of a retrospective chart review of severe sepsis and septic
shock patients in the emergency room (ER) revealed that 25 out of 67 (37.3%) patients had a
delay in initiation of IVF resuscitation.
1. Surviving Sepsis Campaign (SSC) hour-1 care bundle elements include the following:
a. Measure lactate level.
b. Obtain blood cultures before administering antibiotics.
c. Administer broad-spectrum antibiotics.
d. Begin rapid administration of 30 mL/kg intravenous (IV) crystalloid for hypotension
or lactate level > 4 mmol/L - DO NOT DELAY.
e. Vasopressors if hypotension occurs during or after IV fluid (IVF) resuscitation to
maintain MAP > 65 mmHg.
2. SIRS criteria include at least two (2) of the following:
a. Fever > 100.4 or hypothermia < 96.8.
b. Tachypnea > 20 bpm.
c. Tachycardia > 90 bpm.
d. Leukocytosis > 12,000, leukopenia < 4,000, or bandemia > 10% bands.
3. Once sepsis screening is complete and initial IVF resuscitation orders are received,
treatment should begin:
a. As soon as possible.
4. Once sepsis-induced hypoperfusion or septic shock ensues, at least 30 mL/kg of IV
crystalloid should be administered:
a. Within 1 hour.
5. Acting quickly and minimizing delays in treating sepsis and septic shock patients saves
lives.
a. True.
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